New York State Common Retirement Fund Esperion Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 31,400 shares of ESPR stock, worth $68,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,400

Previous 76,500 58.95%

Holding current value

$68,766

Previous $170,000 69.41%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$1.61 - $2.73 $72,611 - $123,123	-45,100 Reduced 58.95%	31,400 $52,000
Q2 2024 Jul 31, 2024	BUY	$1.84 - $3.24 $140,760 - $247,860	76,500 New	76,500 $170,000
Q2 2023 Aug 07, 2023	SELL	$1.2 - $1.76 $29,280 - $42,944	-24,400 Reduced 97.49%	628 $1,000
Q1 2023 May 02, 2023	SELL	$1.46 - $7.3 $29,715 - $148,576	-20,353 Reduced 44.85%	25,028 $40,000
Q4 2022 Jan 30, 2023	BUY	$5.09 - $8.5 $10 - $17	2 Added 0.0%	45,381 $283,000
Q3 2022 Nov 08, 2022	BUY	$5.45 - $8.13 $80,600 - $120,234	14,789 Added 48.35%	45,379 $304,000
Q2 2022 Aug 04, 2022	BUY	$4.77 - $6.67 $19,847 - $27,753	4,161 Added 15.74%	30,590 $195,000
Q1 2022 May 05, 2022	BUY	$3.34 - $5.56 $15,030 - $25,020	4,500 Added 20.52%	26,429 $123,000
Q4 2021 Feb 02, 2022	SELL	$4.81 - $11.92 $132,977 - $329,540	-27,646 Reduced 55.77%	21,929 $110,000
Q3 2021 Nov 02, 2021	BUY	$11.34 - $21.37 $362 - $683	32 Added 0.06%	49,575 $597,000
Q2 2021 Aug 02, 2021	SELL	$19.4 - $28.71 $208,123 - $308,000	-10,728 Reduced 17.8%	49,543 $1.05 Million
Q4 2020 Feb 08, 2021	SELL	$24.2 - $35.76 $188,687 - $278,820	-7,797 Reduced 11.45%	60,271 $1.57 Million
Q3 2020 Nov 05, 2020	BUY	$31.18 - $52.71 $389,750 - $658,875	12,500 Added 22.49%	68,068 $2.53 Million
Q2 2020 Aug 07, 2020	BUY	$30.04 - $51.31 $184,746 - $315,556	6,150 Added 12.44%	55,568 $2.85 Million
Q1 2020 May 06, 2020	SELL	$27.44 - $73.84 $155,831 - $419,337	-5,679 Reduced 10.31%	49,418 $1.56 Million
Q4 2019 Feb 05, 2020	BUY	$35.4 - $59.82 $601,693 - $1.02 Million	16,997 Added 44.61%	55,097 $3.29 Million
Q3 2019 Nov 07, 2019	BUY	$34.47 - $47.53 $430,875 - $594,125	12,500 Added 48.83%	38,100 $1.4 Million
Q2 2019 Aug 09, 2019	BUY	$40.1 - $52.33 $96,240 - $125,592	2,400 Added 10.34%	25,600 $1.19 Million
Q1 2019 May 08, 2019	SELL	$40.11 - $53.57 $288,792 - $385,704	-7,200 Reduced 23.68%	23,200 $931,000
Q4 2018 Feb 08, 2019	SELL	$36.99 - $59.11 $250,681 - $400,588	-6,777 Reduced 18.23%	30,400 $1.4 Million
Q2 2018 Aug 10, 2018	BUY	$36.2 - $76.4 $273,310 - $576,820	7,550 Added 25.48%	37,177 $1.46 Million
Q1 2018 May 10, 2018	SELL	$65.94 - $80.76 $2.68 Million - $3.28 Million	-40,645 Reduced 57.84%	29,627 $2.14 Million
Q4 2017 Feb 13, 2018	BUY	$43.47 - $67.43 $2.36 Million - $3.67 Million	54,372 Added 341.96%	70,272 $4.63 Million
Q2 2017 Aug 11, 2017	BUY	N/A	15,900	15,900 $736,000

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $146M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Esperion Therapeutics, Inc. Transaction History